Reference group choice and antibiotic resistance outcomes

被引：75

作者：

Kaye, KS

Engemann, JJ

Mozaffari, E

Carmeli, Y

机构：

[1] Duke Univ, Med Ctr, Durham, NC USA

[2] Pfizer, New York, NY USA

[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA

来源：

EMERGING INFECTIOUS DISEASES | 2004年 / 10卷 / 06期

关键词：

D O I：

10.3201/eid1006.020665

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used.

引用

收藏

页码：1125 / 1128

页数：4

相关论文

共 14 条

[1] Nosocomial methicillin-resistant and methicillin-susceptible, Staphylococcus aureus primary bacteremia:: At what costs [J].

Abramson, MA ;

Sexton, DJ .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :408-411

[2] Pneumococcal meningitis in the intensive care unit -: Prognostic factors of clinical outcome in a series of 80 cases [J].

Auburtin, M ;

Porcher, R ;

Bruneel, F ;

Scanvic, A ;

Trouillet, JL ;

Bédos, JP ;

Régnier, B ;

Wolff, M .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (05) :713-717

[3] Health and economic outcomes of vancomycin-resistant enterococci [J].

Carmeli, Y ;

Eliopoulos, G ;

Mozaffari, E ;

Samore, M .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2223-2228

[4] Control of endemic methicillin-resistant Staphylococcus aureus -: A cost-benefit analysis in an intensive care unit [J].

Chaix, C ;

Durand-Zaleski, I ;

Alberti, C ;

Brun-Buisson, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1745-1751

[5] The impact of antimicrobial resistance on health and economic outcomes [J].

Cosgrove, SE ;

Carmeli, Y .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :1433-1437

[6] Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality [J].

Edmond, MB ;

Ober, JF ;

Dawson, JD ;

Weinbaum, DL ;

Wenzel, RP .

CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1234-1239

[7] Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection [J].

Engemann, JJ ;

Carmeli, Y ;

Cosgrove, SE ;

Fowler, VG ;

Bronstein, MZ ;

Trivette, SL ;

Briggs, JP ;

Sexton, DJ ;

Kaye, KS .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :592-598

[8] Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus [J].

Harbarth, S ;

Rutschmann, O ;

Sudre, P ;

Pittet, D .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (02) :182-189

[9] Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention - Emory workshop [J].

Howard, D ;

Cordell, R ;

McGowan, JE ;

Packard, RM ;

Scott, RD ;

Solomon, SL ;

Elbasha, EH ;

Gerberding, JL ;

Meltzer, MI ;

Weber, JT ;

Rajbhandary, S ;

Steinberg, JP ;

Flanders, WD ;

Florence, CS ;

Roberts, R ;

Weinstein, RA ;

Goss, TF ;

Song, XY ;

Roghmann, MC ;

Bradham, DD ;

South, BR ;

Bellm, LA ;

Mulligan, MLE ;

Porter, SB ;

Teutsch, S ;

Callahan, M ;

Saint, S ;

Rosenman, R ;

Fraser, VJ .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) :1573-1578

[10]

Menon KV, 1999, J ROY COLL SURG EDIN, V44, P161